Author: Dr. David Lowemann

Trial Finds Experimental Obesity Pill Effective, Safe

Novo Nordisk said on Wednesday its highly anticipated experimental weight-loss pill amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects. The maker of blockbuster drugs Wegovy and Ozempic said in March that a Phase I trial… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on September 11, 2024

Risky play exercises an ancestral need to push limits

Since their invention in the 1920s, jungle gyms and monkey bars have become both fixtures of playgrounds and symbols of childhood injury that anxious caretakers want removed. Anthropologists mark 100 years of the iconic playground equipment by arguing that risky play exercises a biological need passed on from apes and early humans for children to […]

Published on September 11, 2024

Weight-Loss Drug Effective for Kids as Young as 6

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11,… Read Full Article (External Site) […]

Published on September 11, 2024